CLDX: Celldex Therapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
PEG koeffitsiyenti dinamikasi og'ir allergiyalarga qarshi kurashish uchun noyob antitanalarni ishlab chiquvchi Celldex Therapeutics (CLDX) kompaniyasining salohiyatini namoyish etadi. Barzolvolimab ning ortib borayotgan samaradorligi molekulyar modellashtirish va sintezni avtomatlashtirish bilan qo'llab-quvvatlanmoqda, strategik autsorsing esa erta bosqichdagi sinovlarga bo'lgan bog'liqlikni minimallashtiradi. 0.00 ning joriy qiymati metrika darajasini ifodalab, aksiyalarning adolatli qiymatini biznes o'sish sur'atlariga nisbatan aniqlashga yordam beradi.
Celldex Therapeutics (CLDX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Celldex Therapeutics|CLDX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi celldex.com|CLDX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Celldex|CLDX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Celldex Therapeutics|Shoshilinch likvidlik celldex.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CLDX - Kompaniyaning sof foydasi|Kutilayotgan foyda Celldex Therapeutics|CLDX - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Celldex Corp|CLDX - PEG multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Celldex|CLDX - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Celldex Therapeutics|CLDX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi celldex.com|CLDX - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Celldex Therapeutics
Kompaniyaning umumiy tahlili:CLDX - Celldex Therapeutics Inc
Celldex Therapeutics (CLDX) kompaniyasidagi immunologik platformalarning diversifikatsiyasi ilmiy xatarlarni minimallashtirib, antitelalar ishlab chiqishni barqaror kengaytirish uchun asos yaratadi. Xarajatlarning biznesni kengaytirish sur'atlariga nisbatini tahlil qilib, investor joriy bozor ko'paytirgichini foyda tiklanish dinamikasi bilan solishtiradi, bunda birdan past qiymat aktivning biofarmatsevtika sektoridagi kengayish salohiyatiga nisbatan qadrsizlanganligidan dalolat beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Aurinia Pharmaceuticals (AUPH)|biocryst.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - O‘sish sur’atiga tuzatilgan narx-foyda|Pharvaris Corp - PEG multiplikatori|AbCellera Biologics (ABCL) - Narx-foyda va o‘sish multiplikatori|TRML: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda precigen.com (PGEN)|Narxning foydaga va o‘sish sur’atiga nisbati Pharming Group|Narxning foydaga va o‘sish sur’atiga nisbati NKTR|Narxning foydaga va o‘sish sur’atiga nisbati Upstream Bio Corp (UPB)|Narxning foydaga va o‘sish sur’atiga nisbati ZBIO (Zenas Corp)|PEG multiplikatori IMNM (Immunome, Inc.)|GOSS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|KalVista Pharmaceuticals, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Narx-foyda va o‘sish multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti SVRA|Narx-foyda va o‘sish multiplikatori RIGL|ANAB: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori ATXS (Astria Therapeutics, Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati ENGN|PEG multiplikatori RAPT (RAPT Therapeutics, Inc.)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti JBIO|Aclaris Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda kyvernatx.com|Tiziana Life Sciences Ltd (TLSA) - Narxning foydaga va o‘sish sur’atiga nisbati|Cabaletta Bio Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|VTYX (Ventyx Bio) - PEG multiplikatori|PEG multiplikatori Theratechnologies, Inc|Narxning foydaga va o‘sish sur’atiga nisbati Avalo Therapeutics, Inc (AVTX)|ELDN: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori AGEN (Agenus Inc.)|Climb Bio Inc. (CLYM) - O‘sish sur’atiga tuzatilgan narx-foyda|ZURA: Narx-foyda va o‘sish multiplikatori|ATYR - PEG multiplikatori|ADAG (adagene.com) - Narx-foyda va o‘sish multiplikatori|IMA: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|STTK (Shattuck Labs Inc) - PEG multiplikatori|Equillium Bio (EQ) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori CNTB|Narx-foyda va o‘sish multiplikatori immunic-therapeutics.com IMUX|Narxning foydaga va o‘sish sur’atiga nisbati Atara Bio ATRA|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. - PEG multiplikatori|Adicet Bio (ACET) - Narx-foyda va o‘sish multiplikatori|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|INMB (INmune Bio Corporation) - Narxning foydaga va o‘sish sur’atiga nisbati|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti KZR (kezarlifesciences.com)|Narx-foyda va o‘sish multiplikatori SABS (SAB Biotherapeutics, Inc.)|Akari Therapeutics PLC - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB (Q32 Bio Inc) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|GeoVax Labs, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EDSA (edesabiotech.com)|IBIO: PEG multiplikatori|Carisma Therapeutics Inc. (CARM) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|BOLT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|Narx-foyda va o‘sish multiplikatori aptevotherapeutics.com APVO|PEG multiplikatori AIM (AIM ImmunoTech)|PEG multiplikatori Aditxt Inc. ADTX|GRI: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XRTX (XORTX Corp)|HIND: PEG multiplikatori|REVB - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|Narx-foyda va o‘sish multiplikatori Scinai Immunotherapeutics Ltd (SCNI)|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|Narx-foyda va o‘sish multiplikatori affimed.com AFMD|Allakos - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori HOOKIPA Pharma, Inc. HOOK|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|ITOS (iTeos Therapeutics Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|OCEA: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio) - PEG multiplikatori
